Old Web
English
Sign In
Acemap
>
Paper
>
Su2094 Safety and Dosing Study of Glucagon-Like Peptide 2 (GLP-2) in Children With Intestinal Failure
Su2094 Safety and Dosing Study of Glucagon-Like Peptide 2 (GLP-2) in Children With Intestinal Failure
2014
David L. Sigalet
Viona Lam
Vikram Karnik
Mary Brindle
Bolette Hartmann
Dana Boctor
Linda Casey
Bryan Dicken
Sharla Stoffman
Elaine de Heuvel
Gail Wrightwilson
Laurie E. Wallace
Jens J. Holst
Keywords:
Glucagon-like peptide-2
Dosing
General surgery
Intensive care medicine
Diabetes mellitus
Medicine
Pharmacology
intestinal failure
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]